ArticlePloS one2025
A pandemic risk index to improve supply chains decision-making between US and Mexico: A COVID-19 case study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Social Vulnerability Index (SVI) developed by the Centers for Disease Control and Prevention (CDC), has been widely used as a benchmark to measure the state of vulnerability of counties across the United States. The SVI is integrated using a simple aggregation methodology on a set of variables reflecting the region's socioeconomic status, household characteristics, racial & ethnic minority status, and housing type/transportation. Due to its simple construction and inclusion of significant variables publicly available, the SVI has grown exponentially in popularity among organizations and government officials as a tool for decision-making, especially for resource allocation and for regional risk assessment. Furthermore, the COVID-19 pandemic brought a set of unprecedented challenges in the bi-national health between the United States and Mexico, particularly on the state of risk of supply chains. Since the North American Free Trade Agreement (NAFTA) became effective in 1994 and then renewed in 2020 as USMCA, Mexico has grown to be the biggest trading partner of the U.S., fast approaching a trade value of more than a trillion USD a year. For which conducting regional risk assessment following the SVI formulation can be a significant impact for multiple stakeholders and organizations. In this work, the formulation of the SVI is analyzed using a risk framework as a reference, to corroborate its applicability for decision-making, and to expand it to account for variables and processes impacting supply chains during the COVID-19 pandemic. This analysis shows that vulnerability is only one of three factors required to conduct risk assessment (i.e., hazards vulnerability, and consequences), needed to produce a baseline of reference to make informed decisions. A case study is also developed based on the use of the SVI during the COVID-19 pandemic for supply chains between the U.S. and Mexico, by introducing the formulation of a risk index that is compatible with the proposed risk framework. The first step to expand the SVI into a risk index for supply chains between U.S. and Mexico, was to reproduce the CDC methodology, followed by using an Empirical Cumulative Density Function (ECDF) aggregation methodology to justify it statistically, and then to illustrate its benefits and limitations when extended into a new risk index (accounting for the three required risk components). As a result, a bi-national risk index map is produced after harmonizing publicly available variables in the U.S. and Mexico, illustrating the potential to quantify the state of regional risk for supply chains and other path-dependent systems, and setting a reference to further improve it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.